Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00132
|
|||||
Drug Name |
Phosphate
|
|||||
Synonyms |
14265-44-2; AC1L1AN2; AKOS015903596; BDBM50155537; CHEBI:18367; CREATINE PHOSPHATE; CTK0H5978; DTXSID7039672; I14-18227; N-PHOSPHOCREATINE; NBIIXXVUZAFLBC-UHFFFAOYSA-K; NK08V8K8HR; O-Phosphate; Orthophosphate; PO4; PO4(3-); Phosphate ion; Phosphate ions; Phosphates; Phosphoric acid trianion; UNII-NK08V8K8HR; [PO4](3-); a phosphate group; phosphoric acid, ion(3-); tetraoxidophosphate(3-); tetraoxophosphate(3-); tetraoxophosphate(V)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Constipation [ICD11:ME05.0] | Approved | [1] | |||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
O4P-3
|
|||||
Canonical SMILES |
[O-]P(=O)([O-])[O-]
|
|||||
InChI |
InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3
|
|||||
InChIKey |
NBIIXXVUZAFLBC-UHFFFAOYSA-K
|
|||||
CAS Number |
CAS 14265-44-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 94.971 | Topological Polar Surface Area | 86.2 | ||
Heavy Atom Count | 5 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
-2.3
|
|||||
PubChem CID | ||||||
PubChem SID |
103066731
,103077071
,104042950
,104075345
,104296651
,125331104
,125823182
,126524047
,134989311
,135292823
,137001640
,142051012
,14709385
,152043015
,15218698
,163304750
,175268694
,176264609
,176270178
,223741247
,24439414
,3071
,53787703
,56310835
,56311388
,57320705
,7728230
,7889982
,79295108
,8144764
,8150953
,840917
,841057
|
|||||
ChEBI ID |
CHEBI:18367
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | DIC | Transporter Info | Mitochondrial dicarboxylate carrier | Substrate | [2] | |
G3PP | Transporter Info | Glycerol-3-phosphate permease | Substrate | [3] | ||
NPT1 | Transporter Info | Sodium-dependent phosphate transport protein 1 | Substrate | [4] | ||
NPT4 | Transporter Info | Sodium-dependent phosphate transport protein 4 | Substrate | [5] | ||
PHC | Transporter Info | Phosphate carrier protein | Substrate | [6] | ||
PIT1 | Transporter Info | Sodium-dependent phosphate transporter 1 | Substrate | [7] | ||
PIT2 | Transporter Info | Sodium-dependent phosphate transporter 2 | Substrate | [7] | ||
SCAMC1 | Transporter Info | Calcium-binding mitochondrial carrier protein SCaMC-1 | Substrate | [8] | ||
SCAMC2 | Transporter Info | Calcium-binding mitochondrial carrier protein SCaMC-2 | Substrate | [9] | ||
SCAMC3 | Transporter Info | Calcium-binding mitochondrial carrier protein SCaMC-3 | Substrate | [10] | ||
SLC17A4 | Transporter Info | Probable small intestine urate exporter | Substrate | [11] | ||
VGLUT1 | Transporter Info | Vesicular glutamate transporter 1 | Substrate | [12] | ||
VGLUT2 | Transporter Info | Vesicular glutamate transporter 2 | Substrate | [4] | ||
References | ||||||
1 | Phosphate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency. Hum Mol Genet. 2018 Feb 1;27(3):499-504. | |||||
3 | SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One. 2011;6(9):e23157. | |||||
4 | Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem. 2010 Aug 20;285(34):26107-13. | |||||
5 | Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem. 2010 Nov 5;285(45):35123-32. | |||||
6 | The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis. J Biol Chem. 2018 Feb 9;293(6):1887-1896. | |||||
7 | Phosphate transporters and their function. Annu Rev Physiol. 2013;75:535-50. | |||||
8 | De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise. Am J Hum Genet. 2017 Nov 2;101(5):844-855. | |||||
9 | Ketogenic diet induces expression of the muscle circadian gene Slc25a25 via neural pathway that might be involved in muscle thermogenesis. Sci Rep. 2017 Jun 6;7(1):2885. | |||||
10 | Cellular expression and alternative splicing of SLC25A23, a member of the mitochondrial Ca2+-dependent solute carrier gene family. Gene. 2005 Jan 31;345(2):173-82. | |||||
11 | A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am J Physiol Cell Physiol. 2012 Jun 1;302(11):C1652-60. | |||||
12 | SLC17: a functionally diverse family of organic anion transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):350-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.